Emergent BioSolutions (EBS) Intangibles (2010 - 2026)
Emergent BioSolutions (EBS) recorded Intangibles of $261.8 million in Q2 2026, down 44.2% from $469 million a year earlier and down 44.3% from the prior quarter.
Powered by 
Analysis
Emergent BioSolutions (EBS) Intangibles (2010 - 2026) Analysis & Trends
At the end of FY2025, Emergent BioSolutions reported Intangibles of $436.5 million, down 13.0% from FY2024.
- Annual Intangibles has declined for three straight years, with a five-year compound annual growth rate of -8.0% (FY2020 to FY2025).
- Across earlier years, Intangibles came in at $501.5 million in FY2024 (-11.5%), $566.6 million in FY2023 (-22.3%), $728.8 million in FY2022 (+20.5%) and $604.6 million in FY2021 (-8.8%).
- The Q2 2026 figure is the lowest quarterly Intangibles since Q3 2018.
- On a year-over-year basis, Intangibles has declined for 12 consecutive quarters, with an average decline of 14.9% over the last eight quarters.
- Peak year-over-year performance for Intangibles in the last five years was growth of 20.5% in Q4 2022, against a decline of 44.2% in Q2 2026 at the low end.
- Per Business Quant, the preceding three quarters came in at $470.4 million (Q1 2026), $436.5 million (Q4 2025) and $452.7 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,146.94 Bn | 1,115.53 Bn | 19.71 Bn | 18.11 Bn |
| 2 | Johnson & Johnson | 624.96 Bn | 543.49 Bn | 17.26 Bn | 48.23 Bn |
| 3 | AbbVie | 510.15 Bn | 483.27 Bn | 12.70 Bn | 49.14 Bn |
| 4 | Merck | 366.13 Bn | 320.51 Bn | 12.21 Bn | 24.98 Bn |
| 5 | Novartis Ag | 297.75 Bn | 261.74 Bn | 11.24 Bn | 42.07 Bn |
| 6 | Astrazeneca | 261.93 Bn | 235.62 Bn | 12.86 Bn | 37.72 Bn |
| 7 | Amgen | 236.51 Bn | 191.91 Bn | 7.24 Bn | 20.49 Bn |
| 8 | Gilead Sciences | 194.27 Bn | 168.47 Bn | 6.22 Bn | 14.03 Bn |
| 9 | Pfizer | 171.74 Bn | 118.39 Bn | 10.94 Bn | 47.05 Bn |
| 10 | Emergent BioSolutions | 325.34 Mn | -425.56 Mn | 137.20 Mn | 261.80 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 261.80 Mn |
| Mar 31, 2026 | 470.40 Mn |
| Dec 31, 2025 | 436.50 Mn |
| Sep 30, 2025 | 452.70 Mn |
| Jun 30, 2025 | 469.00 Mn |
| Mar 31, 2025 | 485.20 Mn |
| Dec 31, 2024 | 501.50 Mn |
| Sep 30, 2024 | 517.80 Mn |
| Jun 30, 2024 | 534.10 Mn |
| Mar 31, 2024 | 550.40 Mn |
| Dec 31, 2023 | 566.60 Mn |
| Sep 30, 2023 | 582.80 Mn |
| Jun 30, 2023 | 592.80 Mn |
| Mar 31, 2023 | 608.90 Mn |
| Dec 31, 2022 | 728.80 Mn |
| Sep 30, 2022 | 724.90 Mn |
| Jun 30, 2022 | 576.60 Mn |
| Mar 31, 2022 | 590.60 Mn |
| Dec 31, 2021 | 604.60 Mn |
| Sep 30, 2021 | 618.60 Mn |
API Access
Emergent BioSolutions Intangibles API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=intangibles&ticker=EBS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "intangibles", "ticker": "EBS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=intangibles&ticker=EBS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();